Deepak Nitrite Ltd (DEEPAKNTR)
🎯 Key Takeaways
- Deepak Nitrite Ltd is transitioning from a mature commodity chemicals producer to a high-margin specialty chemicals leader through strategic capacity expansion and backward integration. Management is executing a clear growth phase, targeting 4 lakh tonnes phenol capacity and commissioning a polycarbonate project by H2 FY28-FY29, supported by strong financial performance and a disciplined capital structure.
- Revenue grew 21.6% QoQ to ₹2,578 in Q1FY27.
- ⚠️ 1) Over-reliance on phenolics (68.5% of revenue) exposes the company to cyclical commodity demand and pricing pressures despite margin improvements. 2
- Market Cap
- ₹21,155
- P/E Ratio
- 27.0
- P/B Ratio
- 3.62
- ROE
- 13.4%
- ROCE
- 15.3%
- Debt/Equity
- 0.26
- Div Yield
- 0.48%
- Promoter
- 49.3%
📖 The Story
Deepak Nitrite Ltd is transitioning from a mature commodity chemicals producer to a high-margin specialty chemicals leader through strategic capacity expansion and backward integration. Management is executing a clear growth phase, targeting 4 lakh tonnes phenol capacity and commissioning a polycarbonate project by H2 FY28-FY29, supported by strong financial performance and a disciplined capital structure.
📰 What's Happening
In Q1 FY27 (filed August 11, 2026), the company delivered record financials: revenue grew 35% YoY to ₹2,592 crores and PAT surged 207% YoY to ₹345 crores, driven by phenolics (68.5% of revenue) and advanced intermediates. EBITDA rose 159% YoY to ₹554 crores with phenolics EBIT margin expanding to 24%. Management highlighted progress on ammonia-to-amines integration, polycarbonate manufacturing (targeting H2 FY28-FY29 commissioning), and capacity expansion to 4 lakh tonnes phenol. R&D is focused on flow chemistry and fluorination to develop high-value products like acetophenone.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 1,902 | 1,975 | 2,120 | 2,578 |
| Operating Profit | 151 | 153 | 313 | 477 |
| OPM % | 7.9% | 7.8% | 14.8% | 18.5% |
| Net Profit | 119 | 100 | 220 | 345 |
| EPS | ₹8.71 | ₹7.32 | ₹16.11 | ₹25.30 |
The financial trajectory shows a sharp inflection: revenue and profitability have accelerated significantly over the past four quarters, with OPM expanding from 7.8% in Dec 2025 to 18.5% in Jun 2026 and PAT growth exceeding 200% YoY. This margin improvement aligns directly with management’s disclosed focus on operational efficiencies, integrated manufacturing, and higher-value product mix, particularly in phenolics and advanced intermediates, indicating successful execution of their margin enhancement strategy.
🔮 Management Outlook & What's Next
Management is confident in sustained growth, targeting 4 lakh tonnes phenol capacity and polycarbonate project commissioning in H2 FY28-FY29. They are advancing backward integration (ammonia-to-amines), expanding specialty products like acetophenone, and planning debottlenecking with potential 300 KTPA phenol capacity addition. R&D investments in flow chemistry and fluorination signal a strategic push into higher-margin, differentiated chemical segments with global market reach.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 27 | 27 | 27 | 27 |
| Reserves | 5,361 | 5,061 | 5,810 | 5,488 |
| Borrowings | 1,267 | 857 | 1,528 | 1,244 |
| Total Liabilities | 7,718 | 7,009 | 8,681 | 7,884 |
| Fixed Assets | 2,400 | 2,346 | 3,270 | 2,512 |
| Investments | 511 | 394 | 213 | 303 |
| Total Assets | 7,718 | 7,009 | 8,681 | 7,884 |
The balance sheet reflects a strong capital position with net worth of ₹6,214 crores and debt-to-equity of 0.27x as of March 2026. Borrowings have increased slightly from ₹1,244 crores (Mar 2026) to ₹1,528 crores (Mar 2026), but remain well below equity, indicating conservative leverage. Capital is being allocated toward capacity expansion and strategic projects without over-leveraging, supported by robust cash flows and retained earnings.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +539 |
| Investing | -669 |
| Financing | +193 |
| Net Cash Flow | +64 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 49.3% | 49.3% | 49.3% | 49.3% |
| FII | 6.2% | 6.0% | 6.2% | 6.3% |
| DII | 22.7% | 23.2% | 23.5% | 23.8% |
| Public | 19.1% | 18.8% | 18.5% | 18.2% |
| # Shareholders | 4,19,367 | 4,08,560 | 3,96,798 | 3,82,905 |
Institutional investors (FII 6.25%, DII 23.76%) hold a significant stake, with DII accumulation accelerating over the past four quarters (23.76% in Q1FY27 vs 22.7% in Q2FY26). Promoter holding remains stable at ~49.3%. The growing institutional interest and consistent promoter support suggest confidence in long-term prospects, while the expanding shareholder base (3,82,905 shareholders) indicates rising retail participation.
⚖️ Peer Comparison — Chemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.53 L Cr | 57.6 | 33.4% | — | 0.01 |
| SRF | 73,810 | 34.1 | 15.6% | — | 0.36 |
| LINDEINDIA | 52,814 | 96.7 | 17.5% | — | 0.00 |
| FLUOROCHEM | 48,774 | 79.7 | 9.6% | — | 0.34 |
| NAVINFLUOR | 43,256 | 54.7 | 22.2% | — | 0.31 |
| GODREJIND | 36,153 | 30.8 | 9.2% | — | 4.57 |
| HSCL | 33,807 | 42.0 | 20.7% | — | 0.16 |
| AETHER | 23,029 | 97.7 | 13.8% | — | 0.08 |
| DEEPAKNTR | 21,155 | 27.0 | 15.3% | — | 0.26 |
| CASTROLIND | 19,891 | 18.7 | 76.2% | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1) Over-reliance on phenolics (68.5% of revenue) exposes the company to cyclical commodity demand and pricing pressures despite margin improvements. 2) Execution risk in large-scale projects like polycarbonate and capacity expansion could delay returns or strain cash flows if timelines slip. 3) Rising input costs or raw material volatility could pressure margins if not fully passed on to customers. 4) Intensifying competition in specialty chemicals may erode pricing power as new players enter the market.
📋 Recent Filings
- Announcement2026-09-24Deepak Nitrite Ltd announced the closure of its insider trading window effective October 1, 2026, following SEBI regulations and the company's code of…
- Announcement2026-08-26Deepak Nitrite announced that its subsidiaries Deepak Chem Tech and Deepak Phenolics will invest ₹95 crores and ₹80 crores respectively in 9% Optional…
- 🟡 Board Meeting2026-08-21No summary available
- 🔴 Financial Results2026-08-11Deepak Nitrite reported record Q1 FY27 revenue of **₹2,592 crores** (+35% YoY, +22% QoQ) and PAT of **₹345 crores** (+207% YoY, +57% QoQ), driven by s…
- 🟡 Board Meeting2026-08-07Deepak Nitrite Limited announced the effective date of board changes following the cessation of Shri Diteep Choksi as an Independent Director, as comm…
- Announcement2026-08-07Deepak Nitrite announced the cessation of Independent Director Dileep Choksi effective August 7, 2026, following completion of his second term, as man…
- 🟡 Board Meeting2026-08-05Deepak Nitrite Limited shareholders approved all 13 resolutions at the 55th AGM on August 5, 2026, including a ₹7.50 per share dividend (375% of face …
- Announcement2026-08-04Deepak Nitrite reported record Q1 FY27 results with revenue of ₹2,592 crores, up 35% YoY, driven by strong performance in phenolics and advanced inter…
- Announcement2026-07-24Deepak Nitrite Limited announced a conference call on 6 August 2026 at 3:30 PM IST to discuss Q1 FY27 financial results, inviting investors to registe…
- Announcement2026-07-23Deepak Nitrite Limited announced today, July 23, 2026, that it executed a Deed of Guarantee for Bank Muscat SAOG to secure a $78.43 million term loan …
🧠 Analyst's Read
Deepak Nitrite is executing a clear transformation toward high-margin specialty chemicals with strong financial momentum and strategic investments in capacity and R&D. The next watchpoint is the successful ramp-up of polycarbonate production and margin sustainability in new segments — execution will determine whether this growth phase sustains or stalls.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-29.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when DEEPAKNTR files new disclosures
Track DEEPAKNTR filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track DEEPAKNTR — FreeFree account · 2 AI queries/day